July 02, 2021

Smaller companies set for third-quarter catalysts

The third quarter will see important data for Travere, Radius and Sio Gene, among other small developers.

March 25, 2020

Astrazeneca throws Silence an $80m lifeline

Silence has received an important validation, but making progress could be tough.

August 06, 2019

Share price movers – July 2019

December 10, 2018

Silence’s delivery falls short of its promise

September 08, 2016

Interview – Immodulon rises from the ashes of SR Pharma

April 16, 2014

Novartis exit caps tough period for RNAi research

April 10, 2013

Silence needs to make a big noise with new cash

September 15, 2011

EP Vantage Interview – Noxxon's transformation entering pivotal phase

August 31, 2011

Therapeutic Focus - Looking beyond VEGF in diabetic eye disease